Diabetes risk after treatment for childhood and young adult cancer
Cromie KJ, Murray RD, Ajjan RA, et al.
Diabetes Care. 2025:dc242171.
Leggi
Long-term improvements in glycemia and user-reported outcomes associated with open-source automated insulin delivery systems in adults with type 1 diabetes in the United Kingdom: a real-world observational study
Liarakos AL, Crabtree TSJ, Hussain S, et al.
Diabetes Technol Ther. Pub. online 27 Jan 2025.
Leggi
Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trial
Liu Y, Chen Y, Ma J, et al.
BMJ. 2025;388:e081820.
Leggi
Residual C-peptide secretion is associated with better CGM-metrics in adults with short-lasting type 1 diabetes
Amendolara R, Zampetti S, Siena A, et al.
Diabetes Res Clin Pract. 2025:112006.
Leggi
Association between sarcopenia and weight-adjusted waist index in male patients with type 2 diabetes
Xiang Y, Wang Z, Xu J, et al.
BMC Endocr Disord. 2025;25(1):20.
Leggi
Achievement of HbA1c and weight targets in adults with type 2 diabetes on once weekly injectable glucagon-like peptide-1 receptor agonist therapy in UK primary care: a retrospective, real-world study
Gulati K, Wijndaele K, Webb J, et al.
Diabetes Obes Metab. Pub. online 22 Jan 2025.
Leggi
Cumulative risk of diabetic foot complications in risk groups of type 1 and type 2 diabetes: real-world evidence from a 22-year follow-up study
Akerkar A, Rønn PF, Kosjerina V, et al.
Diabetes Obes Metab. Pub. online 22 Jan 2025.
Leggi
Bariatric surgery and cardiovascular outcomes in patients with obesity, metabolic dysfunction-associated steatotic liver disease, and coronary artery disease: a population-based matched cohort study
Krishnan A, Sims OT, Teran D, et al.
Eur Heart J Qual Care Clin Outcomes. 2025:qcaf001.
Leggi